Charles River Laboratorie (CRL) Tops Q4 EPS by 9c
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $285.11 --0%
EPS Growth %: +21.8%
Financial Fact:
Discontinued operations (in dollars per share): 0.01
Today's EPS Names:
NEOV, MANU, CTAS, More
EPS Growth %: +21.8%
Financial Fact:
Discontinued operations (in dollars per share): 0.01
Today's EPS Names:
NEOV, MANU, CTAS, More
Join SI Premium – FREE
Charles River Laboratorie (NYSE: CRL) reported Q4 EPS of $0.81, $0.09 better than the analyst estimate of $0.72. Revenue for the quarter came in at $329.5 million versus the consensus estimate of $318.73 million.
Charles River Laboratorie sees FY2015 EPS of $3.55-$3.65, versus the consensus of $3.58.
For earnings history and earnings-related data on Charles River Laboratorie (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- Bernstein SocGen Group Starts Amphenol (APH) at Outperform
- Jefferies Starts China Oilfield Services (A-Shares) (601808:CH) at Buy
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
